Single Site Errors In Clinical Trials Should Trigger Wider Probe - BIMO
This article was originally published in The Gray Sheet
Executive Summary
Serious data collection problems at a single site of a multi-center trial should prompt an evaluation of the sponsor's entire study management system, FDA participants concluded at Nov 14-15 Bioresearch Monitoring intra-agency stakeholder meeting.
You may also be interested in...
BIMO Clinical Site Investigations Per Application To Decrease In FY 2001
The number of clinical site investigations performed by the FDA Center for Devices and Radiological Health's bioresearch monitoring (BIMO) team will likely decrease from two to three per application to one to two for the remainder of the fiscal year.
BIMO Clinical Site Investigations Per Application To Decrease In FY 2001
The number of clinical site investigations performed by the FDA Center for Devices and Radiological Health's bioresearch monitoring (BIMO) team will likely decrease from two to three per application to one to two for the remainder of the fiscal year.
CDRH's "Strategic Vision" Captures Unique Device Industry Landscape
The Center for Devices and Radiological Health's strategic vision for the next five years will replace the linear premarket/postmarket approach to device regulation with a more holistic program.